PixCell Medical Technologies is a privately held Israeli company developing cell-based point of care (POC) diagnostics devices.
PixCell's technology is based on Viscoelastic Focusing, a patented methodology,and on a proprietary microfluidic based disposable.
PixCell was founded by Prof. Max Herzberg, a leading figure in the biotech industry in Israel, and Dr. Avishay Bransky, an expert in microfluidics and the inventor of the Viscoelastic Focusing technology.
PixCell's first product, HemoScreen™, is a point of care complete blood count (CBC) system. It is CE marked and is already being marketed in Europe. FDA approval for marketing in the US is expected during 2017.
PixCell's innovative technology is a powerful platform for developing portable diagnostic devices based on whole blood analysis.